found that ellagic acid inhibited inflammatory mediator-induced colon cancer in rats, significantly reducing the levels of IL-6, NF-κB, COX-2, and TNF-α in colon cancer cells. This evidence concerns the gene NFKB1 and malignant colon neoplasm.